http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20100112882-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f0e688f4f0f360c3093469970677fdbe |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2521-107 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6813 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6837 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-15 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-15 |
| filingDate | 2009-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_889f662a9b2d904efd4d4568c2a63fd4 |
| publicationDate | 2010-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20100112882-A |
| titleOfInvention | Searching for drugs for the treatment of obesity using peripheral blood mononuclear gene markers, early diagnosis of obesity, and kits for use in the respective methods |
| abstract | The present invention provides a method for detecting obesity treatment and prevention of obesity by using genetic indicators with altered expression in peripheral blood mononuclear cells (PBMCs) in dietary obese rats and early diagnosis of obesity. A method and a kit used for each thereof.n n n The present invention as described above, using the at least one peripheral blood mononuclear gene selected from the group of genetic indicators (UbiquitinD, etc.) found by the inventors of the present invention to search for drugs or the like effective in the treatment of obesity in blood samples or obesity and It is characterized by the early diagnosis of obesity complications.n n n The present invention also relates to at least one peripheral blood mononuclear gene selected from the group of such genetic indicators; Buffer solutions used for hybridization; Reverse transcriptase for synthesizing cDNA from RNA; And it is characterized in that the kit for the detection (or diagnosis), including a dyeing reagent for confirming the expression.n n n In this case, the kit may be manufactured in the form of a cDNA microarray. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3657176-A1 |
| priorityDate | 2009-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 977.